S&P 500   3,286.28 (+0.31%)
DOW   28,845.16 (+0.43%)
QQQ   222.22 (+0.35%)
AAPL   326.73 (+2.85%)
FB   222.46 (+2.14%)
MSFT   167.57 (+1.28%)
GOOGL   1,456.05 (+0.38%)
AMZN   1,864.59 (+0.61%)
CGC   23.81 (-0.46%)
NVDA   245.45 (-1.02%)
BABA   210.84 (+0.29%)
MU   55.94 (-0.94%)
GE   12.96 (+10.40%)
TSLA   577.20 (+1.82%)
AMD   46.75 (-7.50%)
T   37.22 (-3.53%)
F   8.87 (-1.11%)
NFLX   343.63 (-1.40%)
BAC   33.29 (+0.12%)
DIS   137.06 (-0.95%)
S&P 500   3,286.28 (+0.31%)
DOW   28,845.16 (+0.43%)
QQQ   222.22 (+0.35%)
AAPL   326.73 (+2.85%)
FB   222.46 (+2.14%)
MSFT   167.57 (+1.28%)
GOOGL   1,456.05 (+0.38%)
AMZN   1,864.59 (+0.61%)
CGC   23.81 (-0.46%)
NVDA   245.45 (-1.02%)
BABA   210.84 (+0.29%)
MU   55.94 (-0.94%)
GE   12.96 (+10.40%)
TSLA   577.20 (+1.82%)
AMD   46.75 (-7.50%)
T   37.22 (-3.53%)
F   8.87 (-1.11%)
NFLX   343.63 (-1.40%)
BAC   33.29 (+0.12%)
DIS   137.06 (-0.95%)
S&P 500   3,286.28 (+0.31%)
DOW   28,845.16 (+0.43%)
QQQ   222.22 (+0.35%)
AAPL   326.73 (+2.85%)
FB   222.46 (+2.14%)
MSFT   167.57 (+1.28%)
GOOGL   1,456.05 (+0.38%)
AMZN   1,864.59 (+0.61%)
CGC   23.81 (-0.46%)
NVDA   245.45 (-1.02%)
BABA   210.84 (+0.29%)
MU   55.94 (-0.94%)
GE   12.96 (+10.40%)
TSLA   577.20 (+1.82%)
AMD   46.75 (-7.50%)
T   37.22 (-3.53%)
F   8.87 (-1.11%)
NFLX   343.63 (-1.40%)
BAC   33.29 (+0.12%)
DIS   137.06 (-0.95%)
S&P 500   3,286.28 (+0.31%)
DOW   28,845.16 (+0.43%)
QQQ   222.22 (+0.35%)
AAPL   326.73 (+2.85%)
FB   222.46 (+2.14%)
MSFT   167.57 (+1.28%)
GOOGL   1,456.05 (+0.38%)
AMZN   1,864.59 (+0.61%)
CGC   23.81 (-0.46%)
NVDA   245.45 (-1.02%)
BABA   210.84 (+0.29%)
MU   55.94 (-0.94%)
GE   12.96 (+10.40%)
TSLA   577.20 (+1.82%)
AMD   46.75 (-7.50%)
T   37.22 (-3.53%)
F   8.87 (-1.11%)
NFLX   343.63 (-1.40%)
BAC   33.29 (+0.12%)
DIS   137.06 (-0.95%)
Log in

NASDAQ:PRPH - ProPhase Labs Stock Price, Forecast & News

$1.82
-0.16 (-8.08 %)
(As of 01/29/2020 12:36 PM ET)
Today's Range
$1.82
Now: $1.82
$1.82
50-Day Range
$1.78
MA: $1.95
$2.30
52-Week Range
$1.63
Now: $1.82
$3.36
Volume11 shs
Average Volume1,591 shs
Market Capitalization$21.06 million
P/E RatioN/A
Dividend YieldN/A
Beta0.03
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter(OTC) consumer healthcare products, dietary supplements, and other remedies in the United States. The company offers TK Supplements product line include Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support; and Super ProstaFlow+ for prostate and urinary health. In addition, the company provides contract manufacturing services of OTC healthcare and dietary supplements products. It markets its products through national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PRPH
CUSIPN/A
Phone215-345-0919

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.13 million
Book Value$1.43 per share

Profitability

Net Income$-1,740,000.00

Miscellaneous

Employees47
Market Cap$21.06 million
Next Earnings Date3/24/2020 (Estimated)
OptionableNot Optionable

Receive PRPH News and Ratings via Email

Sign-up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter.


ProPhase Labs (NASDAQ:PRPH) Frequently Asked Questions

What is ProPhase Labs' stock symbol?

ProPhase Labs trades on the NASDAQ under the ticker symbol "PRPH."

How often does ProPhase Labs pay dividends? What is the dividend yield for ProPhase Labs?

ProPhase Labs announced a dividend on Wednesday, November 20th. Stockholders of record on Tuesday, December 3rd will be given a dividend of $0.25 per share on Thursday, December 12th. The ex-dividend date of this dividend is Monday, December 2nd. View ProPhase Labs' Dividend History.

How were ProPhase Labs' earnings last quarter?

ProPhase Labs Inc (NASDAQ:PRPH) announced its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.04) earnings per share (EPS) for the quarter. The firm had revenue of $2.77 million for the quarter. ProPhase Labs had a negative return on equity of 20.48% and a negative net margin of 29.05%. View ProPhase Labs' Earnings History.

When is ProPhase Labs' next earnings date?

ProPhase Labs is scheduled to release their next quarterly earnings announcement on Tuesday, March 24th 2020. View Earnings Estimates for ProPhase Labs.

Has ProPhase Labs been receiving favorable news coverage?

News stories about PRPH stock have trended very negative on Wednesday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ProPhase Labs earned a news impact score of -3.3 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an impact on the stock's share price in the near future. View News Stories for ProPhase Labs.

Are investors shorting ProPhase Labs?

ProPhase Labs saw a decrease in short interest during the month of January. As of January 15th, there was short interest totalling 7,800 shares, a decrease of 29.1% from the December 31st total of 11,000 shares. Based on an average trading volume of 3,000 shares, the days-to-cover ratio is presently 2.6 days. Approximately 0.1% of the shares of the stock are short sold. View ProPhase Labs' Current Options Chain.

Who are some of ProPhase Labs' key competitors?

What other stocks do shareholders of ProPhase Labs own?

Who are ProPhase Labs' key executives?

ProPhase Labs' management team includes the folowing people:
  • Mr. Ted William Karkus, Chairman & CEO (Age 60)
  • Ms. Monica Brady, CFO & Chief Accounting Officer (Age 42)

How do I buy shares of ProPhase Labs?

Shares of PRPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ProPhase Labs' stock price today?

One share of PRPH stock can currently be purchased for approximately $1.82.

How big of a company is ProPhase Labs?

ProPhase Labs has a market capitalization of $21.06 million and generates $13.13 million in revenue each year. ProPhase Labs employs 47 workers across the globe.View Additional Information About ProPhase Labs.

What is ProPhase Labs' official website?

The official website for ProPhase Labs is http://www.prophaselabs.com/.

How can I contact ProPhase Labs?

ProPhase Labs' mailing address is 621 NORTH SHADY RETREAT ROAD, DOYLESTOWN PA, 18901. The company can be reached via phone at 215-345-0919 or via email at [email protected]


MarketBeat Community Rating for ProPhase Labs (NASDAQ PRPH)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  88 (Vote Outperform)
Underperform Votes:  114 (Vote Underperform)
Total Votes:  202
MarketBeat's community ratings are surveys of what our community members think about ProPhase Labs and other stocks. Vote "Outperform" if you believe PRPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel